SynthesisBMC urology2020

Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial.

Rongxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.